CTI BioPharma (CTIC) Reports Q3 Loss of $0.28

November 6, 2017 4:03 PM

CTI BioPharma (NASDAQ: CTIC) reported Q3 EPS of ($0.28), versus ($1.04) reported last year.

For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.

Categories

Earnings Guidance